SSRIs and Sexual Dysfunction in Men: Medication Selection

Comparative Sexual Side Effect Profiles

• Bupropion is significantly less likely to cause sexual dysfunction in men compared to SSRIs and should be considered as a first-line alternative when sexual side effects are a concern 1, 2
• Sexual dysfunction is a common side effect of SSRIs, with significant differences in incidence among medications 1, 3
• Paroxetine has higher rates of sexual dysfunction than fluoxetine, fluvoxamine, nefazodone, or sertraline 1, 2
• Bupropion has a significantly lower rate of sexual adverse events than fluoxetine or sertraline 1, 2

Management Options

• For patients requiring antidepressant therapy where sexual dysfunction is a significant concern, bupropion should be considered as a first-line agent 4, 5

Important Caveats and Considerations

• While bupropion has fewer sexual side effects, it may be associated with an increased risk for seizures compared to SSRIs 1, 2
• Venlafaxine may be associated with increased cardiovascular risks 2
• Sexual dysfunction is likely underreported in clinical trials and may be more prevalent than documented 1, 2
• When switching medications, patients should be monitored for discontinuation symptoms and potential changes in depressive symptoms 6
• For patients with comorbid anxiety disorders, SSRIs may still be preferred despite sexual side effects, as bupropion has less established efficacy for anxiety 4

Monitoring and Follow-up

• Assess patient response and adverse effects within 1-2 weeks of initiating therapy 6
• If inadequate response to initial therapy occurs within 6-8 weeks, consider medication adjustment 6

Buspirone for SSRI-Induced Sexual Dysfunction

Mechanism and Evidence

• The National Comprehensive Cancer Network (NCCN) guidelines mention buspirone as a potential off-label treatment option for sexual dysfunction, particularly for low or lack of desire, libido, or intimacy in patients with sexual dysfunction 7, 8
• The NCCN guidelines acknowledge that buspirone has been studied in a few trials involving non-cancer populations for sexual dysfunction, though they note limited safety and efficacy data 7, 8

Clinical Application

• If using buspirone for SSRI-induced sexual dysfunction, start at a low dose and titrate gradually while monitoring for improvement in sexual function 7, 8

Important Considerations and Caveats

• Monitoring for drug interactions is essential when combining medications like buspirone with SSRIs 9

Antidepressant-Associated Libido Effects

Clinical Evidence and Guidelines

• The American Society of Clinical Oncology notes that SSRIs/SNRIs should be stopped in breast cancer patients with sexual dysfunction, as these medications reduce libido and cause anorgasmia, and bupropion may be considered as an alternative 10
• The American College of Physicians suggests that SNRIs (venlafaxine, desvenlafaxine, duloxetine) also impair sexual function and should be avoided when libido is a concern 10, 11

Management of SSRI-Induced Sexual Dysfunction

Assessment and Treatment Approach

• The National Comprehensive Cancer Network recommends determining the specific type of sexual dysfunction, such as erectile dysfunction in men, orgasmic dysfunction, decreased libido, or ejaculatory problems, to guide treatment decisions 12
• Lifestyle modifications, including smoking cessation, weight loss, increased physical activity, and reduced alcohol consumption, can improve sexual function and should be incorporated into treatment plans 12

Pharmacologic Interventions

• Bupropion is significantly less likely to cause sexual dysfunction compared to SSRIs and should be considered as a first-line alternative when sexual side effects are a concern, with a recommended dose of 150-400 mg/day [@2@]
• For men with erectile dysfunction, adding a phosphodiesterase inhibitor (PDE5 inhibitor) such as sildenafil or tadalafil represents a robustly supported augmentation strategy, with sildenafil improving ability to achieve and maintain erections (MD 1.04, 95% CI 0.65 to 1.44, and MD 1.18, 95% CI 0.78 to 1.59, respectively) [@3@]
• Tadalafil significantly improves erectile function (RR 11.50, 95% CI 3.03 to 43.67) [@4@]

Evidence Quality and Clinical Considerations

• The Cochrane review found bupropion 150 mg twice daily showed benefit over placebo (SMD 1.60, 95% CI 1.40 to 1.81) for improving sexual function, though once-daily dosing did not demonstrate significant benefit [@5@]
• Bupropion carries an increased seizure risk compared to SSRIs, particularly at higher doses or in patients with predisposing factors, and should be used with caution [@6@]

Antidepressant Selection to Minimize Sexual Side Effects

Primary Recommendation

• The American College of Physicians guideline explicitly states that bupropion is associated with lower rates of sexual adverse events than fluoxetine and sertraline, and physicians should discuss adverse event profiles before selecting medication 13

Comparative Sexual Dysfunction Rates Among Antidepressants

• Bupropion is the antidepressant of choice when sexual side effects are a concern, as it has significantly lower rates of sexual dysfunction compared to SSRIs like fluoxetine and sertraline 13
• Paroxetine has the highest rates of sexual dysfunction among SSRIs—significantly worse than fluoxetine, fluvoxamine, nefazodone, or sertraline 13, 14

Critical Safety Considerations for Bupropion

• Seizure risk is increased with bupropion, particularly at doses above 300 mg/day or in patients with predisposing factors (history of seizures, eating disorders, abrupt alcohol/benzodiazepine discontinuation) 13, 14
• Bupropion is contraindicated in patients with seizure disorders or bulimia/anorexia nervosa 13

Important Clinical Caveats

• Sexual dysfunction rates are substantially underreported in clinical trials, so real-world incidence is likely higher than published rates 14
• Cognitive behavioral therapy should be considered as an alternative to pharmacotherapy entirely, as it has similar efficacy to antidepressants with no sexual side effects and lower relapse rates 13
• Nausea and vomiting are the most common reasons for discontinuation across all antidepressants, so patients should be counseled about this alongside sexual effects 14

Managing Sexual Dysfunction in Patients Taking Antidepressants

Treatment Strategies

• The American Diabetes Association recommends that PDE5 inhibitors, such as sildenafil or tadalafil, should not be used with nitrates due to serious cardiovascular interactions, in patients with erectile dysfunction 15, 16, 17
• The American Heart Association suggests that evaluating cardiovascular risk factors is crucial in all patients with sexual dysfunction, as erectile dysfunction shares common risk factors with cardiovascular disease 15, 16, 17
• Sexual counseling should involve the partner and address psychological factors, as almost all patients with organic causes are also affected psychologically, according to the American Association of Sexuality Educators 15, 16, 17